High Rate of Chronic Disorders and Demand for Minimally-invasive Therapies to Growth: Catheter-Directed Thrombolysis Market to Touch US$ 808 Million by 2033

In 2023, the catheter-directed thrombolysis market is expected to be worth US$ 454.8 million. By 2033, the market is projected to develop at a CAGR of 5.9% and reach a value of US$ 808 million.

The widespread increase in many chronic diseases like obesity, cancer, kidney ailments, coronary heart disorders, etc., is one of the key factors propelling the growth of catheter-directed thrombolysis devices. Apart from this, the surging health awareness regarding early diagnosis and therapy for deep vein thrombosis disorders and pulmonary embolism is also fueling the market growth.

𝐆𝐞𝐭 𝐀𝐡𝐞𝐚𝐝 𝐨𝐟 𝐭𝐡𝐞 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐨𝐧: 𝐎𝐮𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐊𝐞𝐲 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐂𝐚𝐭𝐡𝐞𝐭𝐞𝐫-𝐝𝐢𝐫𝐞𝐜𝐭𝐞𝐝 𝐓𝐡𝐫𝐨𝐦𝐛𝐨𝐥𝐲𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭! https://www.futuremarketinsights.com/reports/sample/rep-gb-5143

Multiplication of the elderly population, who are susceptible to severe medical conditions, is expected to bolster the requirement for minimal-invasive therapies requiring CDT devices. Moreover, surging investments by several government authorities in the healthcare sector, in addition to the surging consumer medical expenses, are also supporting market growth.

Continuous progress in CDT devices is lowering the risk associated with post-thrombotic syndrome (PTS) and offering high-quality patient care, thus boosting their uptake. Besides, numerous healthcare professionals are showing a preference for MI surgeries, which are a safer alternative than traditional open surgeries, thus acting as another growth propeller.

Over the forecast period, the advent of pharmacomechanical CDT (PCDT) techniques to reduce treatment time and related healthcare costs. This is expected to contribute toward market growth.

The market might be challenged by certain factors. The dearth of modern healthcare infrastructure in developing nations is expected to pose a major hindrance. Other than that, there is a low or absence of knowledge and associated risk with this procedure.

𝐓𝐨𝐩 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐅𝐌𝐈'𝐬 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐂𝐚𝐭𝐡𝐞𝐭𝐞𝐫-𝐝𝐢𝐫𝐞𝐜𝐭𝐞𝐝 𝐓𝐡𝐫𝐨𝐦𝐛𝐨𝐥𝐲𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭:

• The North American catheter-directed thrombolysis industry is expected to gain 53.4% market share, with the United States enjoying the leading position in the region and globe by attaining 47% in the global market.

• Although Europe's market share is less than half of North America's, i.e., Europe garnered a 24.1% market share in 2022. The region still holds a prominent position in the market.

• Germany leads the European market with a market share of 4.7%.

• Japan has a value share of 3.1%, attracting businesses to delve deep into the market for revenue prospects.

• Australia's growth rate in the market, as estimated by FMI, is expected to be 5.2% CAGR over the forecast period.

• China is expected to expand at a robust pace of 7.1% over the forecast period.

• India, another Asian country, is expected to expand at a CAGR of 5.8% from 2023 to 2033.

• The United Kingdom is expected to expand at a CAGR of 4.1% over the forecast period.

• Under the delivery mode category, direct delivery to the blood clot segment is expected to garner a market share of more than 62.8% over the forecast period.

• Based on end users, the hospital segment is expected to grab a value share of more than 47.8%.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐍𝐞𝐰𝐬:

• In August 2022, Boston Scientific Corporation obtained Obsidio, Inc., which is a privately-owned firm that has created Gel Embolic Material (GEM) technology for the coagulum of blood vessels in the peripheral circulatory system.

• In July 2020, iVascular S.L.U introduced its sergeant peripheral support catheter for patients suffering from peripheral artery disorder or difficult anatomy during interventional and diagnostic procedures. The device delivers brilliant pushability and torque capacity due to its tapered shaft design.

𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐇𝐞𝐢𝐠𝐡𝐭𝐞𝐧𝐞𝐝 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐀𝐬 𝐘𝐨𝐮 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐎𝐮𝐫 𝐏𝐫𝐨𝐟𝐨𝐮𝐧𝐝 𝐌𝐞𝐭𝐡𝐨𝐝𝐨𝐥𝐨𝐠𝐲 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5143

𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐤𝐞𝐲 𝐩𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬 𝐩𝐫𝐞𝐬𝐞𝐧𝐭 𝐢𝐧 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞:

• AngioDynamics Inc.
• Boston Scientific Corporation
• iVascular SLU
• Straub Medical AG

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬:

𝐁𝐲 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐌𝐨𝐝𝐞:

• Direct Delivery to Blood Clot Catheter-directed Thrombolysis
• Catheter-directed Thrombolysis by Positioning Medical Device at Clot Site

𝐁𝐲 𝐈𝐧𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧:

• Pulmonary Embolism (PE)
• Deep Vein Thrombosis (DVT)
• Strokes
• Other Indications

𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫:

• Hospitals
• Surgical Centers
• Radiology Clinics

𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧:

• North America
• Latin America
• Asia Pacific
• Middle East and Africa
• Europe

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈'𝐬 𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐨𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧:

Neurovascular Devices / Interventional Neurology Market: https://www.futuremarketinsights.com/reports/neurovascular-devices-market

Knee Reconstruction Devices Market: https://www.futuremarketinsights.com/reports/knee-reconstruction-market

Progressive Pulmonary Fibrosis (PPF) Treatment Market: https://www.futuremarketinsights.com/reports/progressive-pulmonary-fibrosis-ppf-treatment-market

𝐀𝐛𝐨𝐮𝐭 𝐅𝐮𝐭𝐮𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 (𝐅𝐌𝐈)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
𝐅𝐨𝐫 𝐒𝐚𝐥𝐞𝐬 𝐄𝐧𝐪𝐮𝐢𝐫𝐢𝐞𝐬: sales@futuremarketinsights.com
𝐖𝐞𝐛𝐬𝐢𝐭𝐞: https://www.futuremarketinsights.com
𝐁𝐫𝐨𝐰𝐬𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.futuremarketinsights.com/reports/catheter-directed-thrombolysis-market

This release was published on openPR.